Clinical trial
Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC
NCT05244213
Study timeline
Study start (actual)2022-06-04Date precision: day
Registry last updated2024-07-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancerunresolved
EGFR Activating Mutationunresolved
Interventions
Sponsors & collaborators
Guangdong Provincial People's Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05244213 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.